BioSpace News Archive

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced it has signed a long-term lease agreement with Bristol-Myers Squibb Company (NYSE: BMY)

Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., a leading global company in the diagnostic imaging business, today announced the Food and Drug FDA approval for VARIBAR® THIN LIQUID (barium sulfate) for oral suspension which is indicated for modified barium swallow (MBS) studies used to detect and assess the type and severity of swallowing disorders also known as dysphagia.

A new and innovative Transitional Care program has been implemented in Richton, Mississippi thanks to a collaboration between Perry County General Hospital and Allevant Solutions, a joint venture between Mayo Clinic and Select Medical.

When combined with Mevion Proton Therapy Systems, the kVue One and the expansive array of kVue inserts provide clinicians the flexibility to develop and manage treatments that are best suited for each patient’s specific needs.

RealSelf, the leading online resource to learn about aesthetic procedures and connect with the doctors who provide them, today introduces RealSelf VerifiedSM, a first-of-its-kind program that transforms and modernizes the process of choosing a plastic surgeon or aesthetic provider.

A new RealSelf survey conducted online by The Harris Poll¹ reveals 59 percent of women in the U.S. do not know there is a difference between a cosmetic surgeon and a plastic surgeon.

Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical therapies to address unmet needs in dermatology, today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for FMX103

100% Accuracy in Detecting Zygosity Enables Earlier Risk Stratification for Serious Perinatal Complications

Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces that it will release financial results for the three and six months ended June 30, 2019 after the market closes on Monday, August 12, 2019

To ensure its valued customers receive the best service possible Visioneering Technologies Inc., announced that experienced sales executive Suzette Tineo has joined VTI as a Territory Manager to serve eye care professionals in the Los Angeles market.